Loisa Mary Stenberg

Title: Loisa Mary Stenberg: Innovator in Antibody Development

Introduction

Loisa Mary Stenberg is a prominent inventor based in Malmö, Sweden. She has made significant contributions to the field of biochemistry, particularly in the development of antibodies that target specific proteins. Her innovative work has implications for various applications in medical research and diagnostics.

Latest Patents

Loisa holds a patent for "Antibodies binding a gamma carboxyglutamic acid displaying epitope." This patent describes antibodies that are capable of identifying gamma-carboxyglutamic acid (Gla) residues in proteins and peptides. Importantly, these antibodies do not react with glutamic acid (Glu) residues, making them highly specific for their target. The patent also outlines methods for preparing and identifying these antibodies, as well as techniques for detecting Gla in biological fluids and tissue specimens. Furthermore, the antibodies can be utilized for the immunopurification of Gla-containing proteins or peptides through methods such as immunoprecipitation or immunoaffinity chromatography.

Career Highlights

Loisa is associated with Protease Ab, a company focused on developing innovative solutions in the field of proteomics. Her work has led to advancements in the understanding of protein interactions and their implications in health and disease. With her expertise, she has contributed to the growing body of knowledge in antibody development.

Collaborations

Loisa has collaborated with notable professionals in her field, including Johan Stenflo and Mark Alan Brown. These collaborations have enhanced her research and contributed to the successful development of her patented technologies.

Conclusion

Loisa Mary Stenberg is a trailblazer in the field of antibody research, with a patent that showcases her innovative approach to identifying specific protein residues. Her contributions continue to impact the scientific community and advance the understanding of protein interactions.